Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 28, 2017The OncologistOpen Access

The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review

View Full Paper
Ask AI
Bookmark
Share

Authors

FFFadi FarhatConcordia University WisconsinATAlfredo TorresNew York Blood CenterWPWungki ParkMemorial Sloan Kettering Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Farhat et al. (2017) studied this question.

synapsesocial.com/papers/6a830acda250d11ff44cd1f8https://doi.org/10.1634/theoncologist.2017-0126
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer2012 · 58 citations
  2. 2Molecular pharming2011 · 43 citations
  3. 3Biosimilars – Global issues, national solutions2011 · 37 citations